PINK1 and Parkinson disease: Recently, a study used a high-throughput phenotype detection system for drug screening in dopaminergic neurons from induced-pluripotent stem cells (iPSCs) derived from patients with PD due to PRKN or PINK1 mutations (Yamaguchi et al., 2020).